Zoé Lens

发表

The structural organization of the N-terminus domain of SopB, a virulence factor of Salmonella, depends on the nature of its protein partners.

V. Villeret, P. Roblin, V. Receveur-Bréchot, 2013, Biochimica et biophysica acta.

Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator.

C. Locht, V. Villeret, A. Baulard, 2010, ACS chemical biology.

NMR structure of the human Mediator MED25 ACID domain.

V. Villeret, D. Monté, Y. De Launoit, 2011, Journal of structural biology.

Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands

E. Willery, C. Locht, V. Villeret, 2011, Nucleic acids research.

Solution Structure of the N-Terminal Domain of Mediator Subunit MED26 and Molecular Characterization of Its Interaction with EAF1 and TAF7.

V. Villeret, I. Landrieu, D. Monté, 2017, Journal of molecular biology.

Purification of SUMO-1 modified IκBα and complex formation with NF-κB.

V. Villeret, C. Van Lint, Y. De Launoit, 2011, Protein expression and purification.

1H, 15N and 13C assignments of the N-terminal domain of the Mediator complex subunit MED26

V. Villeret, I. Landrieu, J. Baert, 2016, Biomolecular NMR Assignments.

1H, 15N and 13C assignments of the N-terminal domain of the Mediator complex subunit MED26

V. Villeret, I. Landrieu, J. Baert, 2016, Biomolecular NMR assignments.

Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25

V. Villeret, I. Landrieu, D. Monté, 2015, Nucleic acids research.

The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members

V. Villeret, D. Monté, Y. De Launoit, 2013, Nucleic acids research.

Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1.

V. Villeret, C. Van Lint, D. Monté, 2010, Biochemical and biophysical research communications.

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.

C. Locht, V. Villeret, R. Wintjens, 2012, Journal of medicinal chemistry.

Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.

C. Locht, V. Villeret, A. Baulard, 2011, Journal of medicinal chemistry.

Crystal structure of human Mediator subunit MED23

B. Clantin, V. Villeret, E. Pardon, 2018, Nature Communications.

Structural insights into ChpT, an essential dimeric histidine phosphotransferase regulating the cell cycle in Caulobacter crescentus

B. Clantin, V. Villeret, E. Biondi, 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.

Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.

C. Locht, V. Villeret, A. Baulard, 2011, Journal of medicinal chemistry.

Assessment of machine-learning predictions for MED25 ACID domain interactions with transactivation domains

F. Dewitte, Zoé Lens, A. Verger, 2023, bioRxiv.

Assessment of machine‐learning predictions for the Mediator complex subunit MED25 ACID domain interactions with transactivation domains

F. Dewitte, Zoé Lens, A. Verger, 2024, FEBS letters.